Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,784
Closed -$362K 174
2020
Q1
$362K Buy
1,784
+20
+1% +$4.37K 0.24% 47
2019
Q4
$425K Buy
1,764
+11
+0.6% +$2.42K 0.26% 54
2019
Q3
$339K Buy
1,753
+13
+0.7% +$2.5K 0.16% 61
2019
Q2
$321K Buy
1,740
+13
+0.8% +$2.33K 0.16% 67
2019
Q1
$328K Sell
1,727
-14
-0.8% -$2.67K 0.17% 57
2018
Q4
$339K Buy
1,741
+12
+0.7% +$2.34K 0.21% 52
2018
Q3
$358K Buy
1,729
+12
+0.7% +$2.37K 0.2% 53
2018
Q2
$317K Buy
1,717
+12
+0.7% +$2.12K 0.18% 56
2018
Q1
$291K Buy
1,705
+12
+0.7% +$2.2K 0.16% 53
2017
Q4
$294K Buy
1,693
+11
+0.7% +$1.95K 0.18% 52
2017
Q3
$314K Sell
1,682
-90
-5% -$15.9K 0.22% 42
2017
Q2
$305K Buy
1,772
+12
+0.7% +$1.95K 0.24% 49
2017
Q1
$289K Buy
+1,760
New +$292K 0.26% 47

Other funds holding AMGN

Fortis Advisors's AMGN Position: Q2 2020 in Review

Fortis Advisors sold out of Amgen (AMGN) in Q2 2020, closing a stake of 1,784 shares — an estimated $362K sold.

Fortis Advisors first reported a position in AMGN in Q1 2017 and held it in 13 quarters. The position peaked at $425K in Q4 2019. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • Fortis Advisors reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
  • Fortis Advisors sold 1,784 Amgen shares in Q2 2020, an estimated $362K.
  • Fortis Advisors first reported a position in Amgen in Q1 2017 and held it in 13 quarters.
  • Fortis Advisors's Amgen position peaked at $425K in Q4 2019.
  • 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.